🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is the first-in-human phase 1 trial of TQC2731 injection in healthy su...
Status
Unknown
Location
First Affiliated Hospital of Zhengzhou University
Start Date
2021-06-25
Trial ID
NCT04923607
This study is a multicenter, randomized, double-blind, parallel-group, plac...
Status
Recruiting
Location
The People's Hospital of Bozhou
Start Date
2025-03-21
Trial ID
NCT06829784
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Status
Completed
Location
The First Affiliated Hospital of Wannan Medical College
Start Date
2023-12-08
Trial ID
NCT06036927
Treatments Being Tested
This study aims to evaluate the efficacy and safety of TQC2731 injection in...
Status
Completed
Location
Affiliated Hospital of Zunyi Medical University
Start Date
2024-07-04
Trial ID
NCT06451640
Treatments Being Tested
TQC2731 injection is a humanized monoclonal antibody that targets Thymic St...
Status
Recruiting
Location
Zhongda Hosiptal Southeast University
Start Date
2025-09-25
Trial ID
NCT07107256
Treatments Being Tested
This is a phase II, multicenter, double-blind, randomized, parallel group, ...
Status
Completed
Location
GUANGZHOU FIRST PEOPLE's HOSPITAL
Start Date
2022-09-23
Trial ID
NCT05472324
Treatments Being Tested
To evaluate the efficacy and safety of TQC2731 injection in patients with m...
Status
Active Not Recruiting
Location
The First People's Hospital of Chuzhou
Start Date
2024-12-31
Trial ID
NCT06707883
Treatments Being Tested